| Sex-related susceptibility in coronavirus disease 2019 (COVID-19): Proposed mechanisms ZŞ Aksoyalp, D Nemutlu-Samur European journal of pharmacology 912, 174548, 2021 | 18 | 2021 |
| A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021 G Kayki-Mutlu, ZS Aksoyalp, L Wojnowski, MC Michel Naunyn-schmiedeberg's Archives of Pharmacology, 1-22, 2022 | 17 | 2022 |
| Knowledge level and attitude towards complementary and alternative treatment methods among medical students: a cross-sectional survey study in Turkey D Demir-Dora, ZŞ Aksoyalp, C Nacitarhan Current Medical Research and Opinion 36 (9), 1465-1471, 2020 | 7 | 2020 |
| Diabetes Mellitus’ ta Mikrobiyotanın Rolü ve Hedeflenmesi ZŞ AKSOYALP, C NACİTARHAN Türkiye Diyabet ve Obezite Dergisi 5 (1), 51-58, 2021 | 5 | 2021 |
| Iron in infectious diseases friend or foe?: The role of gut microbiota ZŞ Aksoyalp, A Temel, BR Erdogan Journal of Trace Elements in Medicine and Biology 75, 127093, 2023 | 4 | 2023 |
| A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2022 G Kayki-Mutlu, ZS Aksoyalp, L Wojnowski, MC Michel Naunyn-Schmiedeberg's Archives of Pharmacology, 2023 | 4 | 2023 |
| Kardiyovasküler hastalıklarda barsak mikrobiyotasının rolü ZŞ Aksoyalp, C Nacitarhan Türk Hijyen ve Deneysel Biyoloji Dergisi 75 (2), 213-224, 2018 | 4 | 2018 |
| Medical students’ knowledge and awareness levels about biologics and biosimilars: the earlier the better? D Demir-Dora, ZŞ Aksoyalp Expert Opinion on Biological Therapy 22 (2), 245-251, 2022 | 2 | 2022 |
| Optimization of enzyme-linked immunosorbent assay kit protocol to detect trimethylamine N-oxide levels in humans ZS Aksoyalp, BR Erdogan, S Aksun EXCLI journal 22, 263, 2023 | 1 | 2023 |
| Which proteinase-activated receptor-1 antagonist is better?: Evaluation of vorapaxar and parmodulin-2 effects on human left internal mammary artery endothelial function ZŞ Aksoyalp, C Nacitarhan, O Erbasan Life Sciences 286, 120045, 2021 | 1 | 2021 |
| Chronotropic Responses to GLP-1 Receptor Agonists and Sitagliptin in Atria from Diabetic Rats E Akcabag, ZS Aksoyalp, F Oner, Z Bayram, G Ozbey, C Nacitarhan, ... Journal of Cardiovascular Pharmacology, 10.1097, 2024 | | 2024 |
| A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2023 G Kayki-Mutlu, ZS Aksoyalp, L Wojnowski, MC Michel Naunyn-Schmiedeberg's Archives of Pharmacology, 1-22, 2024 | | 2024 |
| A Preliminary Study on the Effect of Deferoxamine on Disruption of Bacterial Biofilms and Antimicrobial Resistance A Temel, ZŞ Aksoyalp | | 2023 |
| Correction to: A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021 G Kayki-Mutlu, ZS Aksoyalp, L Wojnowski, MC Michel Naunyn-Schmiedeberg's Archives of Pharmacology 396 (2), 383, 2023 | | 2023 |
| Koronavirüs Hastalığı 2019 (COVID-19)’da Gastrointestinal Belirtilerin Önemi ve Olası Mekanizmalar ZŞ AKSOYALP, NH TURGUT, K BUHARALIOĞLU Sağlık Bilimleri Dergisi 31 (2), 263-267, 2022 | | 2022 |
| Biyobenzer İlaçlarda İmmunojenisite, Ekstrapolasyon, Değiştirme, Değiştirilebilirlik ve İkame ZŞ Aksoyalp, C Nacitarhan Biyobenzer ve Biyoeşdeğer İlaçlarda Güncel Yaklaşımlar 1, 34-39, 2021 | | 2021 |
| Kardiyovasküler Hastalıklar ve Diabetes Mellitus’ta Periferal N-Metil-D-Aspartat Reseptörleri ZŞ Aksoyalp, C Nacitarhan Nobel Medicus 17 (1), 5-11, 2021 | | 2021 |
cahit nacitarhanAkdeniz Üniversitesiakdeniz.edu.tr üzerinde doğrulanmış e-posta adresine sahip
